Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | PDK1 | Q15118 | 3/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL32679867 | 0.97 | SMN1; SMN2 (0.42) | SMN1; SMN2ALDH1A1TDP1TSHRPDK1 | |
| SCHEMBL26928863 | 0.92 | SMN1; SMN2 (0.41) | SMN1; SMN2ALDH1A1TDP1TSHRPDK1 | |
| SCHEMBL2402957 | 0.92 | SMN1; SMN2 (0.41) | SMN1; SMN2ALDH1A1TDP1TSHRPDK1 | |
| SCHEMBL12079084 | 0.90 | SMN1; SMN2 (0.39) | SMN1; SMN2ALDH1A1TDP1TSHRPDK1 | |
| SCHEMBL44112 | 0.88 | SMN1; SMN2 (0.59) | SMN1; SMN2ALDH1A1TDP1TSHRPDK1 | |
| SCHEMBL8605595 | 0.88 | SMN1; SMN2 (0.59) | SMN1; SMN2ALDH1A1TDP1TSHRPDK1 | |
| SCHEMBL20478200 | 0.88 | SMN1; SMN2 (0.59) | SMN1; SMN2ALDH1A1TDP1TSHRPDK1 | |
| SCHEMBL16430091 | 0.88 | SMN1; SMN2 (0.59) | SMN1; SMN2ALDH1A1TDP1TSHRPDK1 | |
| SCHEMBL25222466 | 0.87 | SMN1; SMN2 (0.58) | SMN1; SMN2ALDH1A1TDP1TSHRPDK1 | |
| Ammonia Solution, Strong SCHEMBL28703768 | 0.87 | SMN1; SMN2 (0.58) | SMN1; SMN2ALDH1A1TDP1TSHRPDK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12624247-B2 | Film | LG CHEM, LTD. (KR) | 2026-05-12 | — | — | US | disclosed |
| EP-3433086-B1 | ENERGETIC MATERIALS | TNO (NL) | 2026-05-06 | — | — | EP | disclosed |
| EP-3787878-B1 | METHODS OF POST-PROCESSING PHOTOFABRICATED ARTICLES CREATED VIA ADDITIVE FABRICATION | STRATASYS INC (US) | 2026-02-18 | — | — | EP | disclosed |
| US-12516000-B2 | Energetic materials | NEDERLANDSE ORGANISATIE VOOR TOEGEPAST-NATUURWETENSCHAPPELIJK ONDERZOEK TNO (NL) | 2026-01-06 | — | — | US | disclosed |
| EP-3917445-B1 | METHODS OF MAKING AND POSTPROCESSING ORTHODONTIC ARTICLES | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2025-11-05 | — | — | EP | disclosed |
| US-12378425-B2 | Thermosetting compositions and forming three-dimensional objects therefrom | STRATASYS, INC. (US) | 2025-08-05 | — | — | US | disclosed |
| EP-2868692-B2 | Stabilized matrix-filled liquid radiation curable resin compositions for additive fabrication | STRATASYS INC (US) | 2025-07-16 | — | — | EP | disclosed |
| WO-2025132333-A1 | CURABLE COMPOSITIONS INCLUDING A POLYESTER (METH)ACRYLATE OLIGOMER | ARKEMA FRANCE (FR) | 2025-06-26 | — | — | WO | disclosed |
| EP-4574858-A1 | CURABLE COMPOSITIONS INCLUDING A POLYESTER (METH)ACRYLATE OLIGOMER | ARKEMA FRANCE (FR) | 2025-06-25 | — | — | EP | disclosed |
| US-20250171566-A1 | LIQUID, HYBRID UV/VIS RADIATION CURABLE RESIN COMPOSITIONS FOR ADDITIVE FABRICATION | STRATASYS INC (US) | 2025-05-29 | — | — | US | disclosed |
| WO-2021039799-A1 | CURABLE COMPOSITION | 株式会社日本触媒 | 2021-03-04 | — | — | WO | disclosed |
| CN-107207868-B | Resin composition, resin film, and electronic component | 日本瑞翁株式会社 | 2020-11-06 | — | — | CN | disclosed |
| EP-3724280-A1 | COMPOSITIONS AND METHODS FOR HIGH-TEMPERATURE JETTING OF VISCOUS THERMOSETS TO CREATE SOLID ARTICLES VIA ADDITIVE FABRICATION | DSM IP Assets B.V. (NL) | 2020-10-21 | — | — | EP | disclosed |
| EP-3532273-A1 | THERMOSETTING COMPOSITIONS AND FORMING THREE-DIMENSIONAL OBJECTS THEREFROM | DSM IP Assets B.V. (NL) | 2019-09-04 | — | — | EP | disclosed |
| EP-3532518-A1 | THERMOSETTING COMPOSITIONS AND FORMING THREE-DIMENSIONAL OBJECTS THEREFROM | DSM IP Assets B.V. (NL) | 2019-09-04 | — | — | EP | disclosed |
| WO-2019117723-A1 | COMPOSITIONS AND METHODS FOR HIGH-TEMPERATURE JETTING OF VISCOUS THERMOSETS TO CREATE SOLID ARTICLES VIA ADDITIVE FABRICATION | DSM IP ASSETS B.V. (NL) | 2019-06-20 | — | — | WO | disclosed |
| WO-2018078160-A1 | THERMOSETTING COMPOSITIONS AND FORMING THREE-DIMENSIONAL OBJECTS THEREFROM | DSM IP ASSETS B.V. (NL) | 2018-05-03 | — | — | WO | disclosed |
| WO-2018078159-A1 | THERMOSETTING COMPOSITIONS AND FORMING THREE-DIMENSIONAL OBJECTS THEREFROM | DSM IP ASSETS B.V. (NL) | 2018-05-03 | — | — | WO | disclosed |
| EP-3122529-A1 | COLOR AND/OR OPACITY CHANGING LIQUID RADIATION CURABLE RESINS FOR ADDITIVE FABRICATION | DSM IP Assets B.V. (NL) | 2017-02-01 | — | — | EP | disclosed |
| US-6121342-A | A SILOXANE COMPOUND HAVING AN OXETANYL GROUP, HYDROLYZABLE AND POLYMERIZABLE TO FORM POLYSILSESQUIOXANE AND A CURED PRODUCTS OF HIGH HARDNESS | TOAGOSEI CO., LTD. (JP) | 2000-09-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12624247-B2 | Film | RAD51, COL2A1, COL1A1 | SMN1; SMN2 237/4885ALDH1A1 949/4885TDP1 914/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.